These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2796878)

  • 41. [Relation between parathormone and 1,25-dihydroxyvitamin D3 in chronic kidney failure].
    Sotorník I
    Vnitr Lek; 1997 Sep; 43(9):615-9. PubMed ID: 9750473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development.
    Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
    Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of calciotropic hormones in vivo in the New Zealand white rabbit.
    Warren HB; Lausen NC; Segre GV; el-Hajj G; Brown EM
    Endocrinology; 1989 Nov; 125(5):2683-90. PubMed ID: 2507295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of calcium regulating hormones in the vertebrates: parathyroid hormone, calcitonin, prolactin, and stanniocalcin.
    Wendelaar Bonga SE; Pang PK
    Int Rev Cytol; 1991; 128():139-213. PubMed ID: 1917377
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of magnesium in neonatal calcium homeostasis: effects of magnesium infusion on calciotropic hormones and calcium.
    Shaul PW; Mimouni F; Tsang RC; Specker BL
    Pediatr Res; 1987 Sep; 22(3):319-23. PubMed ID: 3658552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis.
    Holgado R; Haire H; Ross D; Sprague S; Pahl M; Jara A; Martin-Malo A; Rodriguez M; Almaden Y; Felsenfeld AJ
    J Bone Miner Res; 2000 May; 15(5):927-35. PubMed ID: 10804023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
    Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging roles for calcium-regulating hormones beyond osteolysis.
    Goltzman D
    Trends Endocrinol Metab; 2010 Aug; 21(8):512-8. PubMed ID: 20605729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats.
    Ikeda K; Matsumoto T; Morita K; Yamato H; Takahashi H; Ezawa I; Ogata E
    Endocrinology; 1987 Nov; 121(5):1721-6. PubMed ID: 3311717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
    Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
    J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum calcium, parathyroid hormone, and vitamin D status in children and young adults with sickle cell disease.
    Mohammed S; Addae S; Suleiman S; Adzaku F; Annobil S; Kaddoumi O; Richards J
    Ann Clin Biochem; 1993 Jan; 30 ( Pt 1)():45-51. PubMed ID: 8382020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Calcium controlling hormones and endocrinological tests].
    Fujita T
    Rinsho Byori; 1984 Jan; Spec No 58():78-86. PubMed ID: 6381811
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of secretin on parathyroid hormone and calcitonin secretion.
    Sethi R; Kukreja SC; Bowser EN; Hargis GK; Williams GA
    J Clin Endocrinol Metab; 1981 Jul; 53(1):153-7. PubMed ID: 7240373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of growth hormone replacement therapy on 1,25-dihydroxyvitamin D and calcium metabolism.
    Burstein S; Chen IW; Tsang RC
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1246-51. PubMed ID: 6302126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parathormone, calcitonin, and vitamin D metabolites during normal fracture healing in geriatric patients.
    Meller Y; Kestenbaum RS; Shany S; Galinsky D; Zuili I; Yankovitch N; Giat J; Conforti A; Torok G
    Clin Orthop Relat Res; 1985 Oct; (199):272-9. PubMed ID: 4042489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.
    Breslau NA; Moses AM; Pak CY
    J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of 22-oxacalcitriol on serum calcitriol.
    Dusso AS; Negrea L; Finch J; Kamimura S; Lopez-Hilker S; Mori T; Nishii Y; Brown A; Slatopolsky E
    Endocrinology; 1992 Jun; 130(6):3129-34. PubMed ID: 1597134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.